Rehmatullah Khan has recently joined Mission Pharmaceuticals as Head of Speciality Division Mission Pharma is known for services to the transplant community, patients with mission to explore and market nnovative specialities to break monopoly of Giant MNCs. They have already fast growing products with market leader BIORAL a leading cyclosprine microemulsion, as primary immunosuppression Suprimun (mycophenolate mofetil) an affordable adjunct therapy and ATG Fresinius a useful induction therapy. Mission Pharma will now soon be launching Ganvir oral and injectable form of Gancyclovir for CMV infections in Tx patients, and much needed Tacrolimus a useful CNI, Transplant community all over the country has acknowledged the professional services of Rehmatullah Khan and welcomed him in his new capacity in the fast growing company, soon to be No 1 in Transplantation under the dynamic leadership of Rehmatullah Khan, who joined this company after serving Novartis for more than 24 years in different capacity including the last 15 years associated with Transplantation business and as Business Unit Head he doubled the company business in 2007 from 2003 when he took over as Head of BU.